Back

Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism

28 August 2022 (10:15 - 11:00)
Organised by:
Congress Presentation Part of: Coronary artery disease - Epidemiology, prognosis, outcome 5 Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Debora Sa

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

6 More presentations in this session

Presentation thumbnail
Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes
Doctor F. Wenzl (Zurich, CH)
Abstract Slides
Presentation thumbnail
Prevalence of coronary atherosclerosis in individuals with pre-diabetes and diabetes compared to normoglycemic individuals
Professor C. Ostgren (Linkoping, SE)
Abstract Slides
Presentation thumbnail
Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study
Doctor J. Li (Beijing, CN)
Abstract Slides
Presentation thumbnail
Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and mortality in type 1 diabetes
Doctor H. Segersvard (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals of the general population with and without diabetes mellitus
Doctor P. Haller (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Epidemiology, prognosis, outcome 5

The Event

Event poster

ESC Congress 2022

28 August 2022 10:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources